Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT00230347
This study is intended to establish the practicality of treating cancer in the liver with precisely administered single fractions of high-energy radiation using a radiosurgical (cross-firing) technique. A second purpose is to establish a safe dose for such therapy. Finally, the efficacy of radiosurgical ablation of liver tumors, in terms of radiographic response, will be measured.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Stanford, California, 94305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All the following criteria must be met:
Stanford University
Other
Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04028479
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Idaho Falls, Idaho, United States
View Trial DetailsNCT05411133
Adenocarcinoma, Adenocarcinoma Of Esophagus
Adelaide, Australia
View Trial DetailsNCT06358001
Adenocarcinoma, Autoimmune Diseases
Orange, California, United States
View Trial DetailsNCT05678218
Adenocarcinoma, Bile Duct Diseases
Ghent, Belgium
View Trial Details